saccharomyces boulardii and Reduced Adverse Event

• Vonoprazan-Amoxicillin Dual Therapy with or Without Saccharomyces boulardii Supplementation as a Rescue Regimen for Helicobacter pylori Infection.

  • 2026-04-07
  • Clinical Trial · n = 190
  • Infection and drug resistance 19
  • • Ding-Ni Qu
    • Ze-Xuan Ji
    • Jun-Qi Zhang
    • Xiao-Yong Wang

  • PubMed: 41971394
  • DOI: 10.2147/idr.s594118

  2 Insights on

  • Reduced Adverse Event

  • High evidence
  • Clinical

  The incidence of adverse events was significantly lower in the VAS group (11.6%) than it was in the VA group (32.6%; P < 0.001).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes

  Dose

  250 mg twice daily